KCT0004554招募中未知
Human trials to evaluate the usefulness and safety of CKDHC hangover intake hangover improvement
ChongKunDang Healthcare0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 40(Year)（—）
- 性别
- All
入选标准
- •Persons who meet all of the following conditions are selected as subjects for human application.
- •1) Men and women over 19 years old and under 40 years old
- •2) Those who have had a hangover after drinking alcohol
- •3) Those who consumed more than 1 bottle of soju and less than 3 bottles a week in the past month (based on 17 degrees of soju)
- •4) A person who agrees to participate in the human body application test and writes informed consent before the test starts.
排除标准
- •Persons subject to one or more of the following conditions are excluded from human subjects.
- •1) Those who have a history of severe malignant tumors, cerebrovascular diseases (cerebral infarction, cerebral hemorrhage, etc.), and heart diseases (angina, myocardial infarction, heart failure, arrhythmia requiring treatment) within the last 6 months. Stable subjects may participate in the study at the discretion of the principal investigator.)
- •2) Patients with peptic ulcer and reflux esophagitis
- •3) Those who have had past gastric acid suppression or gastroesophageal surgery
- •4) Alcohol use disorders or alcoholics
- •5) Those who have drunk enough to interfere with the test within one week of the test
- •6) Those who are continuously taking drugs that are likely to affect alcohol metabolism, aspirin, steroid bleeding, nonsteroidal drugs, or painkillers
- •7) Those who have taken medicines and functional foods related to liver function improvement within 2 weeks of the start of the test
- •8) Those with liver function abnormalities
- •9) Those with new function abnormalities
- •10) thyroid disease
- •11) Patients with uncontrolled hypertension (more than 160mmHg systolic blood pressure or more than 100mmHg diastolic blood pressure, measured after 10 minutes of test subjects)
- •12) Diabetics with uncontrolled blood sugar through investigation of medication and medical history
- •13) Those who are pregnant or plan to become pregnant during this human testing period.
- •14) Participation in another clinical trial within one month or plan to participate in another clinical trial during this human trial.
研究者
相似试验
已完成
不适用
A human trial to evaluate the efficacy and safety of Gynostemma pentaphyllum (Thunb.) Makino leaf extract powder on improvement of exercise performanceJPRN-UMIN000044104BTC Corporation100
已完成
不适用
A human study to evaluate the efficacy and safety of extracts of Ficus erecta var. sieboldii King Leaves on arthritis : a randomized, double-blind, placebo-controlled studyDiseases of the musculo-skeletal system and connective tissueKCT0002613Jeju Technopark60
已完成
不适用
A human study to evaluate the efficacy and safety of CKDHC-P29 in men with lower urinary tract symptomsKCT0004585Seoul Metropolitan Government Seoul National University Boramae Medical Center80
招募中
不适用
A human study to evaluate the efficacy and safety of rice bran extract on climacteric symptoms in perimenopausal and postmenopausal womeKCT0003282S&D60
已完成
Unknown
A human study to evaluate the efficacy and safety of the extract of Cornus alba L. for prostate healthKCT0008316Seoul Metropolitan Government Seoul National University Boramae Medical Center10